Connect with us

Business

Cigarettes, tobacco and vapes won’t be sold in vending machines from Monday

Published

on

This post was originally published on this site.

CIGARETTES, TOBACCO AND vapes are banned from self-service and vending machines in Ireland from Monday 29 September.

The machines are often found in pubs and nightclubs, but the Vintners’ Federation of Ireland said their use has been decreasing in recent years.

The upcoming ban is part of the governments wider tobacco and nicotine plan, which aims to reduce smoking prevalence in Ireland to under 5%. Latest CSO figures suggest 18% of the population are current smokers.

Minister for Health, Jennifer Carroll MacNeill TD, has said the move will reduce children’s access to the products.

She said: “Sometimes children have been able to access these harmful products, this is unacceptable, and this ban will ensure that this can no longer happen.”

Advertisement

“This is another significant milestone in implementing our national tobacco control policy. The ban aligns with our broader public health strategy to reduce and prevent tobacco and nicotine use in society and ultimately save lives.”

Minister of State with responsibility for Public Health Jennifer Murnane O’Connor TD said vending machines have been an “avenue of easy access” to nicotine use.

She added their use has been “shown to contribute to early experimentation and long-term addiction.” 

Less popular

Speaking to The Journal, the Vintners’ Federation of Ireland said use of the vending machines had become less popular, but was still relied upon as a source of income for some pubs.

A spokesperson for the group said: “While the number of members using vending machines has declined in recent years, some pubs still rely on them as a small source of ancillary income.”

“We will continue to keep members informed about the change and ensure they understand their obligations under the new law.”

The spokesperson said that staff working in pubs will retain the right to access the machines. 

Readers like you are keeping these stories free for everyone…
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.

Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Business

If you can’t vote in next month’s presidential election, we want to hear from you

Published

on

This post was originally published on this site.

image

ARE YOU AN Irish emigrant abroad who can’t vote in next month’s presidential election?

Maybe you are a British, EU or non-EU citizen living in the Republic who does not have the right to vote in presidential elections?

Or perhaps you are an Irish citizen living in Northern Ireland? Although it’s long been talked about, the right to vote for the president has never been granted to people in the North.

Advertisement

If you fall into any of these groups, we’d love to hear from you.

We’ll be reflecting your views on next month’s election in a forthcoming article. We’d like to find out:

  • Would you like to have the right to vote for the president?
  • Does it bother you that you can’t vote in this election, or do you think it’s fair enough?
  • Who might you vote for if you could?

Please share your thoughts by emailing a paragraph or two (around 200-250 words max) to answers@thejournal.ie.

Please include your name, where you’re from and where you’re living now, and let us know if you’d prefer to remain anonymous.

Readers like you are keeping these stories free for everyone…
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.

Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Continue Reading

Business

Autism campaigner: Autism is not new and does not need to be cured

Published

on

This post was originally published on this site.

image

WHEN DEPUTY DANNY Healy-Rae stood up in the Dáil last week and said that Autism “wasn’t an issue in my day” and that “there were very few in my day”, I felt a familiar pang.

I’ve heard variations of this claim my whole life; the idea that Autistic people are somehow a new problem for society.

Danny Healy-Rae also suggested that vitamin deficiencies might be a cause of Autism. Now, with US President Donald Trump and his Health Secretary Robert F. Kennedy Jr. repeating the myth that paracetamol causes Autism, misinformation is coming from both sides of the Atlantic.

These narratives are not just wrong; they are deeply damaging.

Autism is not a new discovery

Autism is not a 21st-century invention. Long before paracetamol, Tylenol, or modern diagnostic manuals, observers described people with behaviours and sensory sensitivities that map onto what we now recognise as Autism. Scholars believe figures like Michelangelo, Sir Isaac Newton, and Albert Einstein may have been Autistic. In France in the 1800s, Victor of Aveyron, sometimes called “the wild boy of Aveyron”, showed behaviours we would now recognise as Autistic traits.

Soviet psychiatrist Grunya Sukhareva published detailed case studies of children with narrow interests and social difficulties in 1925, almost two decades before the word “Autism” entered mainstream psychiatric literature.

These are not curiosities; they are evidence that Autistic ways of being have always existed.

The truth is, Autistic people were there in Danny Healy-Rae’s day; we just weren’t seen. Many were kept at home, institutionalised, or pushed to the margins of society. If you think back to your own classroom, you probably remember a child who kept to themselves or was written off as “odd”. That child may have been Autistic.

Many people are only being identified now because diagnostic criteria, awareness, and reduced stigma mean that parents and adults are more willing to seek help for their children or themselves.

Girls and women have been under-recognised because they mask, learning social scripts to blend in. Research documents this “female camouflage” effect and its role in later or missed diagnoses. Masking isn’t harmless; it has real costs for mental health and well-being. Autistic burnout often mimics depression.

Calls for a ‘cure’

For Autistic people, the endless chatter about a cause or cure is deeply distressing. It frames our existence as a problem rather than a way of being human.

As a child, I banged my head off walls to regulate myself. As a teenager, I hurt myself to cope. My mother could not take me anywhere that was bright or noisy. Those struggles haven’t vanished; I learned to manage, and my meltdowns happen behind closed doors. That is what being Autistic can look like.

Language matters. When leaders speak of Autistic people as something that must be explained away, they reduce our lives to statistics or pathology. That rhetoric fuels stigma and prioritises “fixing” over supporting.

For many Autistic people, the goal is not to be cured, but to be accepted, accommodated, and resourced.
Advertisement

The world should be changed to include us, not the other way round.

Attempts to pinpoint a cause

Trump and RFK Jr. claimed this week that the most common painkiller used in pregnancy causes Autism. It is right to scrutinise any potential risk to pregnant people and babies, but science must follow evidence, and large, well-designed studies that control for family and genetic factors have found no causal link.

A major Swedish population study that initially found small associations with paracetamol used sibling comparisons, but when they compared siblings, they found that both the one exposed to paracetamol and the one not exposed could be Autistic at similar rates. That showed the small link they saw at first wasn’t caused by the medicine itself; it was due to other shared family or genetic factors.

Worse than the scientific uncertainty is how claims about “causes” are weaponised.

Andrew Wakefield’s infamous 1998 paper linking the MMR vaccine to Autism was later retracted as fraudulent, but not before it caused panic, plummeting vaccination rates, and cast Autistic people as the “cost” of immunisation.

Nearly 30 years later, this myth still circulates widely online. Wakefield had financial motives, profiting from undermining the combined MMR with his own vaccine. His fraud was both dangerous and lucrative.

So when I hear Trump and RFK Jr. pushing paracetamol as the supposed cause, I can’t help but ask, what “cure” will follow? Who will swoop in with a “safe alternative”, a supplement, a miracle therapy? Who is lining their pockets while families are whipped into fear, and Autistic people are treated as broken? Who benefits from you believing this?

We need supports, not stigma

Autism is a lifelong neuro-developmental difference shaped by complex genetic and environmental factors, and it is part of human diversity. The World Health Organisation and major research bodies make this clear.

Autism exists, but services don’t. Across Ireland, families are waiting years for assessment. Children are being left without school places or forced to travel hours for appropriate education.

Perhaps it is time we turned the lens around.

Our brains, like our appearances, are diverse. Autism and ADHD are not rare pathologies but part of the natural spectrum of humanity. I explain it to my kids like this: “You are an iPhone, and I’m an Android. We just run on different operating systems.” Neither is broken, neither needs curing; they just work differently.

Autism is also not a straight line from “mild” to “severe.” It is more like a pie chart, with slices representing communication, sensory needs, executive function, and more.

I also live with Ehlers-Danlos Syndrome, and research shows that conditions like EDS and hypermobility often overlap with neurodivergence, including Autism and ADHD. That shows how complex human biology is, and how wrong it is to look for a single “cause” of Autism. We are messy, diverse beings, and Autism is part of that natural complexity, not a mysterious illness.

What is truly distressing is the constant view of Autistic people as a problem to be solved, something to be prevented or cured. We are not broken. We are part of human diversity. Until people in power understand that, families like mine will keep being failed.

Evie Nevin has a degree in journalism. She is an Autistic mother of two, actor, advocate for neurodivergent and disabled people, public speaker, and political campaigner based in West Cork.

Readers like you are keeping these stories free for everyone…
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.

Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Continue Reading

Business

Kingspan chases Magnificent Seven energy with plan to float unit riding on AI boom

Published

on

Read more on post.

Fed up with Kingspan shares drifting behind peers and the wider market, Gene Murtagh is seeking to tap into some of the energy of the Magnificent Seven (Mag-7), the US tech stocks that have driven a three-year bull run across global equity markets.

The Kingspan chief executive revealed on Tuesday that the insulation giant founded 60 years ago by his father, Eugene, plans to float 25 per cent of its advanced building systems unit Advnsys, which is focused on supplying the global data centres boom, in Amsterdam.

The mushrooming of data centres has been turbocharged by the artificial intelligence (AI) revolution that has driven the share prices in recent times of Mag-7 stalwarts such as chipmaker Nvidia, Microsoft, Google-parent Alphabet and Meta, owner of Facebook and Instagram.

Close to $7 trillion (€6 trillion) will need to be spent on data centres globally by 2030, driven by demand for hubs equipped to handle AI processing loads, McKinsey, the management consultancy firm, estimated in a recent report.

“We’re acutely cognisant of the fact that relevant sector peers – and these are not building sector peers, they’re tech-end peers that are supplying the data centre market – are trading at and above 20 times Ebitda,” Murtagh said on a call with analysts, referring to how others in the data centre space are being valued by the stock market at more than 20 times earnings before interest, tax, depreciation and amortisation. Valuing Advnsys along these lines would give it an initial market capitalisation of at least €6 billion.

Kingspan shares soar on potential €6bn flotation of unit riding data centres boomOpens in new window ]

Kingspan had lost more than a third of its market value in the four years before the move was announced – and was down 21 per cent on the year as it grappled with what Murtagh recently described as an ongoing “pretty unforgiving environment” for construction suppliers globally as households and businesses fret about a potential recession. The group is trading at about 10 times Ebitda – compared with its 10-year average of 13.5.

Compare that with Vertiv, an Ohio-based provider of critical infrastructure and services for data centres, whose stock has soared more than 400 per cent over the past four years.

Or with Trane Technologies, the Swords-headquartered but New York-listed maker of heating and cooling systems for commercial buildings, whose market value has more than doubled in the same period, to $90 billion, amid a surge in demand for its data centre air-cooling systems.

The NFL comes to Dublin: How it became the richest sports league in the world

Listen | 26:19

The AI boom – like red-hot stock market trends before it – has attracted blatantly cynical pivots and rebrands from companies trying to jump on the bandwagon.

But Kingspan has been a supplier to the data centres market since before Murtagh became CEO 20 years ago. The new Advnsys unit being lined up for an initial public offering (IPO) – which combines its data centre solutions and light, air and water businesses into one – is a world leader in bespoke critical infrastructure primarily focused on data centres, ventilation and daylighting.

Kingspan trades profit for position in US roofing raceOpens in new window ]

While about 40 per cent of Advnsys’s earnings currently come from providing infrastructure to the tech sector, particularly to data centres, this is expected to grow to about 75 per cent of an even bigger business in the next three to five years, according to the group.

Citigroup analysts reckon the subsidiary could more than double its revenue and Ebitda between 2024 and 2030, to €3.2 billion and €525 million, respectively.

Shares in Kingspan jumped as much as 13.5 per cent to €74.85 on Tuesday morning, but have since handed back almost half their gains as some analysts urged caution.

“While we understand the [market] reaction, particularly in light of the stock’s weaker performance year-to-date, we do not yet understand how a partial IPO creates additional value, nor how the market will arbitrage valuation between the two businesses,” said JP Morgan analysts led by Elodie Rall in a note to clients.

Advnsys may attract a higher valuation multiple, but this is likely to be offset by the market giving the rest of the business – comprising insulated panels, other insulation solutions and its roofing and waterproofing unit – a lower one, she said.

Kingspan plans €650m share buy back as half year revenues rise 8% to record €4.5bnOpens in new window ]

Bernstein’s Pujarini Ghosh said the market excitement earlier in the week had been “overdone” and her €70 price target on the group points to almost 3 per cent downside from here. A listing of Advnsys in New York “could potentially have helped unlock greater value given the business mix will be more heavily skewed to the US”, she said.

About 45 per cent of the unit’s business is exposed to the US, but this is expected to rise well above 50 per cent in the coming years.

Murtagh said the decision to float on Euronext Amsterdam is down to the high level of trading in stocks in that market, a lack of stamp duty there, too, and how the same accounting standard (IFRS) applies to companies in the Netherlands and Ireland.

For sure, the level of trading in Euronext Dublin has slumped over the past five years amid a number of company exits and a dearth of fresh IPOs.

How Kingspan stands to benefit from AI boomOpens in new window ]

But to avoid the 1 per cent stamp duty applied to share trading in Irish companies, Kingspan will need to incorporate Advnsys as a public limited company – or naamloze vennootschap (NV) – in the Netherlands.

A nice bonus from the planned IPO is that it would, according to Murtagh. leave both Kingspan and Advnsys “essentially with zero debt” – giving them plenty of scope to invest and grow by acquisition.

Whereas Kingspan’s share price tends to move with the broader construction industry cycle, Advnsys’s stock will be far more sensitive to developments in AI, making it potentially much more volatile.

Chinese tech group DeepSeek, for example, showed the world earlier this year that its approach to generative AI needs just a fraction of the computing power of more prominent US tools, such as ChatGPT. Could demand for data centres decline as AI systems become more efficient?

One thing’s for sure: savvy investors in Advnsys in Amsterdam will have alerts set for anything coming from another company 9,000km away. For now, Nvidia in Santa Clara, California, remains the bellwether for all things AI.

Continue Reading

Trending